Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K

Moderna on Friday lowered the high end of its 2025 revenue outlook due to a delay in vaccine shipments to the U.K., but beat Wall Street's expectations for the second quarter as it works to cut costs. Shares of Moderna fell more than 6% in premarket trading on Friday. The biotech company now…